EDITORIAL
Treatment-induced neuropathy of diabetes: an energy crisis?
Paediatric epilepsy surgery: making the best of a tough situation
A mouse model of autoimmune encephalitis
A new TRAIL in Alzheimer's disease therapy
Vision and vision-related outcome measures in multiple sclerosis
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states
Identifying the ischaemic penumbra using pH-weighted magnetic resonance imaging
Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes
System xc̄ is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice
Reduced anterior insula, enlarged amygdala in alcoholism and associated depleted von Economo neurons
Temporal lobe surgery in childhood and neuroanatomical predictors of long-term declarative memory outcome
Human N -methyl D-aspartate receptor antibodies alter memory and behaviour in mice
Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination
Post-stroke fatigue: a deficit in corticomotor excitability?
Neural substrates underlying stimulation-enhanced motor skill learning after stroke
Motion area V5/MT+ response to global motion in the absence of V1 resembles early visual cortex
Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy
Auditory spatial processing in Alzheimer's disease
Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease
Normalizing effect of heroin maintenance treatment on stress-induced brain connectivity
Apraxia: the rise, fall and resurrection of diagrams to explain how the brain works
From The Archives
Occipital bending in depression
Reply: Occipital bending in depression
Is nucleus accumbens atrophy correlated with cognitive symptoms of Parkinson's disease?
Reply: Is nucleus accumbens atrophy correlated with cognitive symptoms of Parkinson's disease?
‘Behr syndrome’ with OPA1 compound heterozygote mutations
Reply: ‘Behr syndrome’ with OPA1 compound heterozygote mutations